Literature DB >> 10830250

Antibacterial use in pregnancy.

T M Weller1, E N Rees.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10830250     DOI: 10.2165/00002018-200022050-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Morbidity and drugs in pregnancy: the influence of illness and drugs on the aetiology of congenital malformations.

Authors: 
Journal:  J R Coll Gen Pract       Date:  1975-09

2.  Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil.

Authors:  W Manka; R Solowiow; D Okrzeja
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

3.  Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.

Authors:  E B Samrén; C M van Duijn; S Koch; V K Hiilesmaa; H Klepel; A H Bardy; G B Mannagetta; A W Deichl; E Gaily; M L Granström; H Meinardi; D E Grobbee; A Hofman; D Janz; D Lindhout
Journal:  Epilepsia       Date:  1997-09       Impact factor: 5.864

4.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

5.  Drug use in pregnancy: how to avoid problems.

Authors:  J M Rao; R Arulappu
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

6.  Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992.

Authors:  R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

Review 7.  Metronidazole use in obstetrics and gynecology: a review.

Authors:  M O Robbie; R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1983-04-01       Impact factor: 8.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.